(Q50127386)

25 February 2018

title

Double-Blind Pilot Trial of Oral Tolerization with Myelin Antigens in Multiple Sclerosis (English)

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.7680493

12 August 2024

0 references

Hafler DA

1 reference

25 February 2018

Endel John Orav

object named as

Orav EJ

1 reference

25 February 2018

author name string

H. L. Weiner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7680493

12 August 2024

G. A. Mackin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7680493

12 August 2024

M. Matsui

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7680493

12 August 2024

S. J. Khoury

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7680493

12 August 2024

D. M. Dawson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7680493

12 August 2024

language of work or name

English

0 references

publication date

1 February 1993

1 reference

25 February 2018

26 February 1993

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7680493

full work available at URL

12 August 2024

https://www.science.org/doi/pdf/10.1126/science.7680493

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.7680493

12 August 2024

1 reference

25 February 2018

volume

259

1 reference

25 February 2018

issue

5099

1 reference

25 February 2018

page(s)

1321-1324

1 reference

25 February 2018

Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein

cites work

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.7680493

A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis

12 August 2024

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.7680493

Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the lewis rat and strain 13 guinea pig

12 August 2024

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.7680493

Inhibition of Experimental Drug Allergy by Prior Feeding of the Sensitizing Agent

12 August 2024

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.7680493

Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation

12 August 2024

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.7680493

Cell-mediated immunity to myelin-associated glycoprotein, proteolipid protein, and myelin basic protein in multiple sclerosis

12 August 2024

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.7680493

Cognitive change following MPTP exposure.

12 August 2024

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.7680493

Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lipopolysaccharide

12 August 2024

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.7680493

Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4,

12 August 2024

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.7680493

Multiple sclerosis (first of two parts).

12 August 2024

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.7680493

Antigen-driven bystander suppression after oral administration of antigens

12 August 2024

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.7680493

Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. V. Hierarchy of suppression by myelin basic protein from different species

12 August 2024

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.7680493

Proceedings of the National Academy of Sciences of the United States of America

12 August 2024

421

1992

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.7680493

The regulation of immune responses to dietary protein antigens

12 August 2024

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.7680493

Proceedings of the National Academy of Sciences of the United States of America

12 August 2024

7443

1986

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.7680493

T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis

12 August 2024

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.7680493

Progress in Multiple Sclerosis Research

12 August 2024

page(s)

429

publication date

1980

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.7680493

Immunotherapy of multiple sclerosis

12 August 2024

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.7680493

Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group

12 August 2024

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.7680493

Proceedings of the National Academy of Sciences of the United States of America

12 August 2024

10252

1991

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.7680493

12 August 2024

Identifiers

1 reference

25 February 2018

1 reference

25 February 2018